CTXR — Citius Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $105.77m
- $86.02m
- 29
- 39
- 46
- 32
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -15.6 | -17.5 | -23.1 | -33.6 | -32.5 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.928 | 1.48 | 1.52 | 4.46 | 6.91 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.2 | -0.867 | -2.72 | 0.24 | -4.01 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -12.4 | -16.9 | -24.3 | -28.4 | -29.1 |
Capital Expenditures | 0 | -0.002 | -40 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | — | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -0.002 | -40 | 0 | 0 |
Financing Cash Flow Items | 0 | — | 18.5 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 11.1 | 22.9 | 120 | 0 | 13.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.29 | 5.97 | 56.2 | -28.4 | -15.2 |